# Study of SNH-118110 in Advanced Solid Tumors

> **NCT07649200** · PHASE1 · NOT_YET_RECRUITING · sponsor: **ScinnoHub Pharmaceutical Co., Ltd.** · enrollment: 240 (estimated)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** SNH-118110 Soft Capsules

## Key facts

- **NCT ID:** NCT07649200
- **Lead sponsor:** ScinnoHub Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-26
- **Primary completion:** 2027-06-26
- **Final completion:** 2029-06-26
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07649200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07649200, "Study of SNH-118110 in Advanced Solid Tumors". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07649200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*